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To the Editor—We disagree with Lui et al’s assertion 
that “data concerning Asian Chinese populations are 
meagre”1 with respect to mammographic screening. 
By selective citation, the authors neglected an entire 
corpus of local evidence since 1996,2-4 including their 
own unit’s 1998 report.5
 We have shown that, under the most optimistic 
assumptions, for every 10 000 women 50 years or older 
screened annually over a 10-year period, we would 
expect 1037 ‘positives’ of whom 898 would be falsely 
labelled. This would avert seven breast cancer–related 
deaths but generate 13 iatrogenic complications.3 In 
their audit, among a highly self-selected group of 
women including some with a strong family history of 
breast malignancies, the authors confirmed that only 
5 out of 100 abnormal mammograms turned out to be 
cancer.1 Additionally, contrary to their claim about a 
higher cancer detection rate between 1993-1995 and 
1998-2002, it actually remained flat at 5.0% overall 
(compared to 4.94% in the preceding period).5 Their 
‘improved’ ability to detect ‘minimal’ cancers (3.8 vs 
2.8 per 1000) was almost certainly an artefact due to 
the younger age distribution of those screened in the 
latter period, ie classical case-mix bias.1
 While such statistics do not immediately 
rule out screening as part of a comprehensive 
preventive strategy, this evidence should be clearly 
communicated to women thereby allowing for 
informed choice. At the public health level, mass 
screening will be highly inefficient.4 Resources that 
may be allocated for breast screening, opportunistic 
or population-based, would be better directed at 
improving treatment for cancer patients including 
the funding of new adjuvant therapies, along with 
active case-finding in the minority of high-risk well 
women for whom mammography may be a truly 
beneficial and vital intervention. The authors should 
heed their predecessors’ advice on the “need for 
reconsideration of offering screening to women 40 
years and over”.5
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To the Editor—We thank Dr Leung and his colleagues 
for their interest in our article “Opportunistic breast 
cancer screening in Hong Kong: a revisit of the Kwong 
Wah Hospital experience”.1
 Since the publication of the earlier report 
mentioned by Leung et al,2 we have done two more 
reports on our screening services1,3 and our article1 
was the most comprehensive report describing the 
largest population, longest study period, and giving 
the most detailed analysis. Our data3 have also been 
quoted in an article reviewing the Singapore National 
Breast Screening Programme with a comment that 
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our cancer detection rates were comparable to the 
Singapore Project.4
 The comment “data concerning Asian Chinese 
population are meagre” referred to clinical data on 
the performance of screening programmes in the 
region. Our citation was based on practical data and 
not estimated or projected data.
 Despite Hong Kong having a lower cancer 
incidence compared with western countries, we have 
achieved a 5 per 1000 cancer detection rate, reflecting 
the quality and effectiveness of our screening 
programme. Moreover, there was definitely an 
improved ability to detect small cancers. The screened 
population was older in this study (paragraph 2, page 
1111), just the opposite of the assertion made by 
Leung et al.
 In opportunistic breast cancer screening, 
financial effectiveness is not the main concern. 
Women’s screening decisions are mainly based on 
risks and benefits and we agree with Dr Leung and 
his colleagues that the risks and benefits of a breast 
cancer screening programme should be clearly 
communicated. Our paper gave a factual report on 
our opportunistic screening programme, which is 
both financially sustainable and of good quality. The 
question of whether population screening should 
be performed in Hong Kong is beyond the scope of 
this paper. The differences between opportunistic 
screening and population screening were clearly 
specified in the paper.1
 We fully appreciate Dr Leung and his colleagues’ 
contribution to the evaluation of breast screening in 
Hong Kong and hope our article provides further data 
useful for the future evaluation of breast screening.
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